葉酸 Folate × 憂鬱症

結論:證據支持但有警示

The totality of evidence supports a grade B for folate/L-methylfolate in depression, strictly as an adjunct to antidepressant therapy.

B 🟡 B 初步證據 附警語發布 🚨 high — heavy affiliate marketing in TW community
⚠️ 標記 ⚠️ 廠商資助研究 🇹🇼 台灣在地警示 💊 檢驗 / 藥物交互作用

The totality of evidence supports a grade B for folate/L-methylfolate in depression, strictly as an adjunct to antidepressant therapy. Multiple meta-analyses (PMID 34794190, 34450256, 38873435) converge on a small-to-modest add-on benefit (SMD roughly -0.38 to -0.42; response RR roughly 1.25 to 1.36), and the pivotal RCTs (PMID 23212058) found 15 mg/day L-methylfolate effective while 7.5 mg/day was non-significant, establishing a real but dose-dependent effect. Three independent academic clinical sources (Mayo, Cleveland Clinic, Harvard) and the American Psychiatric Association all describe it as a recognized but modest adjunctive option, never as standalone treatment. The grade is held at B rather than A because effect sizes are modest, quantitative meta-analytic subsets are small (N=483 to 507) with confidence intervals near unity for remission, several pivotal trials are manufacturer-sponsored, one major meta-analysis carries a disclosed industry-linked COI, and benefit is concentrated in subgroups (low folate status, MTHFR variants, obesity, elevated inflammation). This matches Examine's grade B for the primary Depression Symptoms outcome.

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.58
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
B · 附警語發布
信心度
76%
證據方向大致一致
證據層級
E2
多篇高品質統合分析(≥2 篇一致)

各層「支持此療效」的程度

分數越低=該層越不支持
L5 臨床機構權威立場
0.40
L3 機轉生理合理性
0.65
L11 AI 複核獨立判讀
0.65
L1 Examine國際基準
0.70
L2 PubMed原始文獻
0.70
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.577
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Systematic Review and Meta-Analysis of L-Methylfolate Augmentation in Depressive Disorders
PMID: 34794190 2022 統合分析 n = 6,707
結論:Qualitative assessment of 9 articles (N=6,707). Meta-analysis of 3 studies (N=483) showed adjunctive L-methylfolate associated with a small effect on categorical response versus antidepressant monotherapy (RR 1.25, 95% CI 1.08 to 1.46, p=0.004); 4 studies (N=507) showed a continuous-measure effect (SMD -0.38, 95% CI -0.59 to -0.17, p=0.0003).
⚠️ 廠商資助 效應量:RR 1.25 (95% CI 1.08-1.46); SMD -0.38 (95% CI -0.59 to -0.17)
前往 PubMed
Folate as adjunct therapy to SSRI/SNRI for major depressive disorder: Systematic review & meta-analysis
PMID: 34450256 2021 統合分析
結論:6 RCTs identified, 5 pooled. Adjunct folate produced lower depression scores (MD -2.16, 95% CI -3.62 to -0.69, p=0.004), higher response rate (RR 1.36, 95% CI 1.16-1.59, p=0.0001) and higher remission rate (RR 1.39, 95% CI 1.00-1.92, p=0.05) versus SSRI/SNRI monotherapy.
效應量:MD -2.16 points; RR response 1.36; RR remission 1.39
前往 PubMed
L-methylfolate as adjunctive therapy for SSRI-resistant major depression: results of two randomized, double-blind, parallel-sequential trials
PMID: 23212058 2012 RCT (double-blind) n = 223
結論:Trial 1 (148 patients, 7.5-15 mg) showed no significant group differences. Trial 2 (75 patients, 15 mg/day) showed adjunctive L-methylfolate significantly more effective than SSRI plus placebo on both primary outcomes; number needed to treat approximately 6. These are the pivotal trials underpinning the 15 mg/day adjunctive dose.
⚠️ 廠商資助 效應量:NNT approximately 6 (Trial 2, 15 mg/day); Trial 1 non-significant
前往 PubMed
Folate supplementation as a beneficial add-on treatment in relieving depressive symptoms: A meta-analysis of meta-analyses
PMID: 38873435 2024 Umbrella Review
結論:11 meta-analyses included, 8 pooled (5 of RCTs, 3 of observational studies). Folate supplementation significantly reduced depressive symptoms (SMD -0.42, 95% CI -0.57 to -0.27, p<0.001; WMD -3.20, 95% CI -4.00 to -2.41); low serum folate raised depression odds 35% (OR 1.35). Effect greater with supplementation over 10 weeks.
學術資助 效應量:SMD -0.42 (95% CI -0.57 to -0.27); WMD -3.20 points
前往 PubMed

L4a US FDA
支持
Health claims relating folate to risk of neural tube defects may be made on the label or in labeling of foods, including dietary supplements, provided that the requirements in this section are met. 來源↗
L4b EU EFSA
支持
L4c UK NHS
中性
It's recommended that all women who could get pregnant should take a 400 microgram folic acid supplement daily before pregnancy and until they're 12 weeks pregnant. 來源↗
L4d TW TFDA / 衛福部
支持
孕期缺乏葉酸,會增加胎兒腦及脊髓先天性神經管缺陷的風險。育齡婦女及準備懷孕婦女可在準備階段每日攝取400微克,懷孕期間每日攝取600微克。 來源↗
L4e WHO
中性
Current evidence suggests that folic acid supplementation in the periconceptional period, either alone or in combination with other vitamins and minerals, can prevent neural tube defects. 來源↗

L5a NIH Office of Dietary Supplements
支持
L5b Mayo Clinic
謹慎
A low level of folate has been associated with depression. If you have depression, it may be worth talking to your doctor about folic acid as a supplement. 來源↗
L5c Cleveland Clinic
謹慎
L5d Harvard Health
謹慎
L5e Specialty Society (condition-mapped)
謹慎

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 極高
📍立場總覽

台灣社群(PTT/Dcard/Mobile01)對葉酸的討論幾乎全集中於備孕/懷孕情境,鮮少有人專門針對「葉酸治憂鬱症」分享實測心得;少數情緒相關提及多被包進 B 群業配懶人包,非真實鄉民經驗。

💬社群實感

無共識(葉酸用於憂鬱症幾乎無真實社群實測討論)

破解迷思 社群最常見的 3 個誤解
事實把葉酸與 B 群(B6/B12)混為一談,認為「補 B 群=補葉酸=改善情緒」,忽略葉酸僅為其中一環
事實誤以為葉酸是治療憂鬱症的保健品;社群實際語境幾乎全是備孕/懷孕,與抗憂鬱無關
事實受『情緒/疲勞 B 群懶人包』業配文影響,誤把行銷話術當成鄉民實證經驗
🏷️ 社群熱議品牌

依論壇被提及頻率,非銷售或品質排序。

  • DHC(B 群/葉酸,社群暱稱『國民制服』)
  • Vitabox 維他盒子
  • 薇爾(艾伯美妍 B 群+C+鐵)

⚠️ 列出僅代表「TW 社群討論度高」,不代表本站推薦或背書。本站不販售任何產品、無導購連結。

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

孕哺兒媽媽葉酸口嚼錠:60錠/盒,成分為葉酸400微克,每日補充1顆,價格約NT$499

代表來源 ↗
L10b · TFDA 法定身份 官方認定

懷孕婦女自懷孕前1個月至整個孕期,每日應攝取600微克葉酸,且不宜超過1000微克

來源 ↗

  • 心理治療(CBT/人際治療)
  • 抗憂鬱藥物(SSRI 等)
  • 規律運動
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 4 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v31 engine_version: v1.0 claim_id: CLM-COND-depression-INT-folate-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-depression-INT-folate-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "葉酸能改善憂鬱症",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 3,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🟡 B 初步證據"
  }
}